These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Kim JS; Kim JS; Cho MJ; Song KS; Yoon WH Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):403-8. PubMed ID: 12243814 [TBL] [Abstract][Full Text] [Related]
5. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Kim JC; Kim TW; Kim JH; Yu CS; Kim HC; Chang HM; Ryu MH; Park JH; Ahn SD; Lee SW; Shin SS; Kim JS; Choi EK Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):346-53. PubMed ID: 15913913 [TBL] [Abstract][Full Text] [Related]
6. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer. Marsh Rde W; George TJ; Siddiqui T; Mendenhall WM; Zlotecki RA; Grobmyer S; Hochwald S; Chang M; Larson B; King J Am J Clin Oncol; 2010 Jun; 33(3):251-6. PubMed ID: 19823074 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Osti MF; Agolli L; Bracci S; Masoni L; Valeriani M; Falco T; De Sanctis V; Maurizi Enrici R Int J Colorectal Dis; 2014 Jul; 29(7):835-42. PubMed ID: 24825722 [TBL] [Abstract][Full Text] [Related]
9. Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer. de las Heras M; Arias F; del Moral-Avila R; Gómez-Millán J; Jiménez E; Wals A; Tisaire JL; Alcantara MP Clin Transl Oncol; 2013 Apr; 15(4):294-9. PubMed ID: 22855196 [TBL] [Abstract][Full Text] [Related]
10. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. Velenik V; Anderluh F; Oblak I; Strojan P; Zakotnik B Croat Med J; 2006 Oct; 47(5):693-700. PubMed ID: 17042060 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. Kim JS; Kim JS; Cho MJ; Yoon WH; Song KS J Korean Med Sci; 2006 Feb; 21(1):52-7. PubMed ID: 16479065 [TBL] [Abstract][Full Text] [Related]
12. Preoperative radiotherapy combined with capecitabine chemotherapy in Chinese patients with locally advanced rectal cancer. Jin J; Meng H; Zhou G; Xu X; Xue Z; Xu X; Wang F; Lu W; Li X; Zhang H; Deng J J Gastrointest Surg; 2011 Oct; 15(10):1858-65. PubMed ID: 21796454 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Velenik V; Ocvirk J; Music M; Bracko M; Anderluh F; Oblak I; Edhemovic I; Brecelj E; Kropivnik M; Omejc M Radiat Oncol; 2011 Aug; 6():105. PubMed ID: 21880132 [TBL] [Abstract][Full Text] [Related]
14. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306 [TBL] [Abstract][Full Text] [Related]
15. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Velenik V; Oblak I; Anderluh F Radiat Oncol; 2010 Sep; 5():88. PubMed ID: 20920276 [TBL] [Abstract][Full Text] [Related]
16. Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients. Ausili Cèfaro G; Genovesi D; Vinciguerra A; Augurio A; Di Tommaso M; Marchese R; Borzillo V; Tasciotti L; Taraborrelli M; Innocenti P; Colecchia G; Di Nicola M Tumori; 2012; 98(5):622-9. PubMed ID: 23235758 [TBL] [Abstract][Full Text] [Related]
17. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study. Zhu J; Liu F; Gu W; Lian P; Sheng W; Xu J; Cai G; Shi D; Cai S; Zhang Z Radiat Oncol; 2014 Mar; 9():70. PubMed ID: 24606870 [TBL] [Abstract][Full Text] [Related]
18. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186 [TBL] [Abstract][Full Text] [Related]
19. Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART). Ricardi U; Racca P; Franco P; Munoz F; Fanchini L; Rondi N; Dongiovanni V; Gabriele P; Cassoni P; Ciuffreda L; Morino M; Filippi AR; Aglietta M; Bertetto O Med Oncol; 2013; 30(2):581. PubMed ID: 23606239 [TBL] [Abstract][Full Text] [Related]
20. Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer. Jin T; Zhu Y; Luo JL; Zhou N; Li DC; Ju HX; Fan YT; Liu Y; Zhu YP; Feng HY; Liu LY Int J Colorectal Dis; 2015 Mar; 30(3):337-45. PubMed ID: 25564344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]